Effects of Lomitapide on Carotid and Aortic Atherosclerosis in Patients Treated With Lomitapide in Usual Care (CAPTURE)

Trial Profile

Effects of Lomitapide on Carotid and Aortic Atherosclerosis in Patients Treated With Lomitapide in Usual Care (CAPTURE)

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2017

At a glance

  • Drugs Lomitapide (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms CAPTURE
  • Sponsors Aegerion Pharmaceuticals
  • Most Recent Events

    • 13 Dec 2017 Planned primary completion date changed from 1 Apr 2021 to 1 Dec 2018.
    • 13 Dec 2017 Planned initiation date changed from 1 Apr 2015 to 1 Jun 2015.
    • 13 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top